Hot sale product, manufacturer, high purity GLP-1 Semaglutide CAS NO.910463-68-2

Over 10years experiences in the filed of peptides, can solve most of the problems you may made when cooperation.

High quality:

Quality is life. Quality is the most important element for all goods. We have labs doing research in Shanghai and Guangzhou China. HPLC and NMR are available if needed for each peptides.

Reasonable price:

We provide high quality products with competitive price in China. All customers are welcomed to send us inquiries and get quotation.

Low MOQ:

Don't worry about the small order, our MOQ is one box for each product. For some, we can send 1-3vials for free, customer only need to pay the international shipping fee.

Good service:

Fast response. We promise to reply within 24 hours including holidays. Also send quotation and other documents within 48 hours.

Fast shipping and secure courier:

We promise to send out products and provide tracking number within 3 working days if the products are available in store. For customs type, we will finish for 5-10 working day. We have professional agents in many city that can help us send via different couriers based on different destination countries. Over 95% parcels can receive smoothly to customers hand. Even seized in customs, we have reshipping policy. Normally pay 50% value og the goods, we resend.

Semaglutide** is a medication primarily used for the treatment of **type 2 diabetes** and **chronic weight management**. It belongs to the **GLP-1 (glucagon-like peptide-1) receptor agonist** class, which mimics the action of the natural hormone GLP-1 to regulate blood sugar and appetite. Below is a detailed overview:


### **Key Uses**
1. **Type 2 Diabetes Management**  
   - Brand names: **Ozempic** (injection), **Rybelsus** (oral tablet).  
   - Improves glycemic control by:  
     - Stimulating insulin secretion (glucose-dependent).  
     - Suppressing glucagon release.  
     - Slowing gastric emptying.  
   - Reduces risk of major cardiovascular events (e.g., heart attack, stroke) in patients with diabetes and heart disease.

2. **Weight Management**  
   - Brand name: **Wegovy** (higher-dose injection).  
   - Approved for adults and adolescents (12+) with:  
     - Obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions (e.g., hypertension, type 2 diabetes).  
   - Promotes satiety and reduces hunger via central nervous system effects.

### **Mechanism of Action**  
- **GLP-1 Receptor Agonism**: Binds to GLP-1 receptors in the pancreas, brain, and gastrointestinal tract.  
- **Blood Sugar Control**: Enhances insulin secretion and inhibits glucagon release when blood glucose is high.  
- **Weight Loss**: Slows gastric emptying and acts on brain receptors to reduce appetite and calorie intake.


Dosing
- **Ozempic**: Subcutaneous injection, once weekly.  
  - Start: 0.25 mg/week for 4 weeks, then escalate to 0.5–2.0 mg/week.  
- **Wegovy**: Subcutaneous injection, once weekly.  
  - Start: 0.25 mg/week, gradually increasing to 2.4 mg/week over 16–20 weeks.  
- **Rybelsus**: Daily oral tablet (taken on an empty stomach).  
  - Start: 3 mg/day for 30 days, then escalate to 7 mg or 14 mg.